Menopause and the Pelvic Floor: What Changes and What Physiotherapy Addresses

Pelvic floor symptoms become more common with age: population studies report any urinary incontinence in roughly 25% to 45% of women in most surveys, with more than 40% of women aged 70 and over affected, and anatomical prolapse is common after the menopause. What does not change is the guideline: NICE NG123 applies to women aged 18 and over, NG210 to women aged 12 and over, and neither sets an upper limit on who should be offered supervised pelvic floor muscle training¹².

I am not through the menopause, so this article is not written from inside the experience of it. The thing I can contribute is a piece of misinformation I absorbed early and held for years: that leaking was a young mother’s problem that either resolved or turned into an old woman’s problem, and that the middle of that range was a waiting room. It is not. Read red flags and when to stop and get checked first, because several symptoms at this stage of life need a doctor rather than a programme.

What changes, described carefully

Tissue, load history and symptom mix, over years rather than at a moment.

The pelvic floor is muscle and connective tissue, and both change with age. The vaginal walls and surrounding tissues change after the menopause in ways that affect comfort, sensation and sometimes support. Alongside that, a lifetime of load has accumulated: births, chronic straining on the toilet, chronic cough, heavy lifting and pelvic surgery all sit in the history. The International Urogynecological Association publishes plain-language patient material describing these structures and the symptoms associated with them³.

Two things follow that are worth separating. Rising prevalence with age is well documented. Attributing all of it to the menopause specifically is a step further than the figures in this article support, because age, parity and accumulated load all move in the same direction over a life.

The prevalence figures, with their definitions attached

Every number here means something different, and the differences are the point.

• Any urinary incontinence: population studies from many countries report a range of about 5% to 70%, with most reporting 25% to 45%, and more than 40% of women aged 70 and over affected¹.
• Any leakage in a community sample: in the Norwegian EPINCONT survey of 27,936 community-dwelling women aged 20 and over, 25% had leakage of any kind and nearly 7% had significant incontinence, defined as moderate or severe and experienced as bothersome. Of those with incontinence, about half had stress type, 36% mixed and 11% urgency⁴.
• Prolapse by symptoms: about 3% to 6%; by vaginal examination: up to 50%⁵.
• Prolapse on examination after the menopause: among 16,616 women aged 50 to 79 with a uterus who had a baseline pelvic examination in the Women’s Health Initiative, uterine prolapse 14.2%, cystocele 34.3%, rectocele 18.6%⁶.

Put the last two side by side. Anatomical change on examination is common in this age group, and being troubled by it is far less so. Those are two different questions and the answer to one is not an answer to the other, which is exactly the mechanism by which a real symptom gets described as universal and therefore untreatable. Prolapse symptoms versus prolapse stage works through it in detail.

What the guideline says about age, which is nothing

There is no upper limit anywhere in it.

NICE NG123 covers women aged 18 and over and recommends offering a trial of supervised pelvic floor muscle training of at least 3 months’ duration as first-line treatment for stress or mixed urinary incontinence, and considering at least 16 weeks for symptomatic stage 1 or 2 prolapse⁷. NG210 covers women aged 12 and over, offers the same 3 month programme for stress or mixed urinary incontinence, and asks for consideration of at least 4 months for symptomatic prolapse not extending more than 1 cm beyond the hymen on straining².

Neither guideline contains an age at which first-line treatment stops being first-line. NG210 goes further in the other direction: recommendations 1.3.9 to 1.3.11 encourage women of all ages to do pelvic floor muscle training and to continue it throughout life². So this is both a treatment question and a maintenance one.

The structure applies too: programmes should be supervised by a physiotherapist or other healthcare professional with the appropriate expertise, with at least one review to assess progress during a programme and one at the end, and continuation afterwards if beneficial.

What the evidence supports at this stage

The same treatment, with the same caveats this site attaches everywhere.

In the Cochrane review of 31 trials and 1,817 women comparing pelvic floor muscle training against no treatment, placebo, sham or another inactive control, 56% of women with stress urinary incontinence were cured against 6% of controls, a risk ratio of 8.38 with a 95% confidence interval of 3.68 to 19.07, from 4 trials and 165 women, graded high certainty; cure or improvement was 74% against 11%; and across all types of incontinence, cure was 35% against 6%⁸. Quality of life was not pooled, is graded low certainty and should not be quoted as a single effect size, and the authors note that limited follow-up beyond the end of treatment leaves long term outcomes uncertain.

There is no separate post-menopausal effect size in that review to hand you, and this site is not going to derive one. What the trials do not show is any basis for treating age as a reason to skip first-line treatment.

The long term picture is worth knowing for anyone starting later in life. A systematic review of 19 studies following 1,141 women for between 1 and 15 years found long term adherence varying between 10% and 70%, long term success among the original responders between 41% and 85%, and surgery rates at long term follow-up between 4.9% and 58%, and concluded that short term outcomes could be maintained at long term follow-up without incentives for continued training⁹. Keeping it up after discharge treats that honestly.

The symptom mix can shift, and that changes the programme

This is the practical detail most worth taking to an appointment.

Leaking that was purely effort-related can acquire an urgency component, and a pattern of pure urgency can gain an effort component. The proportions in the population give a sense of how mixed a picture is common: about half stress type, 36% mixed and 11% urgency among women with incontinence in EPINCONT⁴.

That matters because the treatments differ. Stress urinary incontinence responds to muscle training as first-line; urge incontinence and overactive bladder is not named in that first-line recommendation and leads with bladder training instead; and mixed urinary incontinence is treated by addressing the dominant symptom first. Describing a change in pattern precisely, ideally with a three-day bladder diary, is what allows somebody to work out which of those you are now in.

Where medication sits, and why it is not on this page

Outside the scope, deliberately.

This site writes nothing about medication, including topical and vaginal oestrogen, beyond naming that it is a conversation for a clinician. That boundary is editorial rather than a judgement about any treatment. What it means practically is that if dryness, discomfort or urinary symptoms are part of your picture, that is worth raising with a doctor or specialist nurse alongside a physiotherapy referral rather than instead of one, and asking a question commits you to nothing.

The same applies to sexual symptoms. NICE NG210 includes sexual dysfunction within the scope of non-surgical management for women aged 12 and over², and what a physiotherapist assesses and treats there is the muscular component: resting tone, ability to release, tenderness and tolerance. Pelvic pain and vaginismus covers pain-led presentations, including the important point that for an overactive floor conventional strengthening is the wrong direction, which is set out in hypertonic pelvic floor and downtraining.

What a programme addresses here

The same components as at any age, weighted differently.

Muscle training where the assessment supports it, prescribed and progressed rather than handed over as a leaflet: see pelvic floor exercise programmes explained and how to do a pelvic floor contraction correctly. Bladder habit, fluids and caffeine: see bladder training and fluid advice. Bowel habit, because straining is a daily competing load and constipation becomes more common: see bowel habit and defaecation technique and constipation and obstructed defaecation.

For prolapse, a pessary is a conservative option that sits beside training rather than after it, fitted by a clinician: see vaginal pessaries alongside physiotherapy and pelvic organ prolapse. And staying active is part of the plan rather than a risk to be avoided: returning to running and lifting covers how load is staged rather than forbidden.

The sentence to be wary of

“It is your age.”

It is the same move as “it is normal after babies”, applied twenty years later, and it works the same way: a true statement about prevalence used as a false statement about treatability. More than 40% of women aged 70 and over report urinary incontinence¹, and the guideline first-line treatment applies to every one of them.

Why symptoms get dismissed and how to be heard covers how to reframe that conversation into one with a checkable answer, getting referred to pelvic health physiotherapy covers the routes, and pelvic floor physiotherapy sets out the treatment in full.